Close

Heat Biologics (HTBX) Suspends Proposed Offering of Common Stock; to Explore Alternative Options

July 22, 2016 8:04 AM EDT Send to a Friend
Heat Biologics, Inc. (“Heat”) (Nasdaq: HTBX), an immuno-oncology company developing novel therapies that activate a patient’s immune system against cancer ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login